Mean platelet volume and the extent of coronary artery disease: results from a large prospective study

Giuseppe De Luca1, Matteo Santagostino, Gioel Gabrio Secco

  • 1Division of Cardiology, Azienda Ospedaliera-Universitaria Maggiore della Carità, Eastern Piedmont University, Corso Mazzini 18, Novara, Italy. giuseppe.deluca@maggioreosp.novara.it

Atherosclerosis
|May 12, 2009
PubMed

Insights

Mean platelet volume (MPV) does not correlate with the extent of coronary artery disease or platelet aggregation. This finding suggests MPV is not a reliable marker for platelet reactivity or a risk factor in coronary artery disease.

Area of Science:

  • Cardiology
  • Hematology
  • Vascular Biology

Background:

  • Platelets are crucial in coronary artery disease (CAD) pathogenesis.
  • Mean platelet volume (MPV) indicates platelet activation and reactivity.
  • The association between MPV and CAD extent requires further investigation.

Purpose of the Study:

  • To determine if mean platelet volume (MPV) correlates with the extent of coronary artery disease.
  • To assess the relationship between MPV and platelet aggregation.
  • To evaluate MPV as a potential marker for platelet reactivity and CAD risk.

Main Methods:

  • MPV was measured in 1411 patients undergoing coronary angiography.
  • Coronary artery disease extent was assessed by stenosis percentage.
  • Platelet aggregation was evaluated using PFA-100 and Multiplate assays.

Main Results:

  • Higher MPV was associated with older age, diabetes, hypertension, and CVA.
  • MPV showed inverse relation to platelet count and association with baseline glycaemia.
  • MPV was not associated with coronary artery disease extent, carotid IMT, or platelet aggregation.

Conclusions:

  • Mean platelet volume (MPV) is not related to platelet aggregation.
  • MPV does not correlate with the extent of coronary artery disease or carotid intima-media thickness.
  • MPV is not a reliable marker for platelet reactivity or a risk factor for coronary artery disease.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...